fbpx

想報名的活動 0

首頁 \ 支持好生活  \ 癌症101先導計劃: 為肺癌患者導航 提供全面的支援服務

癌症101先導計劃: 為肺癌患者導航 提供全面的支援服務

癌症患者面對的挑戰

每位癌症患者在抗癌的道路上均面對著不同大大小小的挑戰,由徵狀的浮現、診斷的過程、治療的決策、治療中的不適、治療後的復康,每個階段都為癌症患者及其照顧者帶來很多疑惑、不安、恐懼及擔憂,令人難以喘息。儘管現時社區已建立很多資源來幫助癌症患者,但在這資訊泛濫的時代,加上複雜的醫療體系,癌症患者要及時在對的時間找到對的資源確實不容易。當中肺癌患者及其照顧者的處境可能更不容易,因為在香港社會相對比較少只針對肺癌患者的支援及援助計劃,而肺癌患者的治療是分秒必爭,患者及照顧者很多時都沒有多餘的時間和心力去尋找支援。有見及此,羅氏大藥廠成立了癌症101先導計劃,率先服務肺癌患者及其照顧者,從經濟、生理、心理上全面支援他們。

 

計劃簡介

癌症101計劃旨在改善患者在癌症道路上的體驗。是一個專為癌症病人設計的導航計劃,由羅氏大藥廠的病人專家主理,團隊包括註冊護士。病人專家會為參與支援計劃的肺癌患者或其照顧者進行單對單的評估,了解參與者在經濟、生理、心理、資訊及實務上的需要,從而更有針對性和更有效地將患者連接合適的社區資源。在此計劃中,羅氏會與不同的病人組織及非牟利機構合作,透過緊密溝通,務求為患者帶來更有效率及個人化的體驗。除了為患者導航,病人專家也會把評估結果分享給參與者,好讓參與者更明白自己的需要,亦可方便患者或照顧者與醫療團隊或其他人溝通。

癌症101計劃是一個為期一年的先導計劃,費用全免,支援香港所有已確診的肺癌患者及其照顧者,計劃除了提供實用資訊外,更連接患者到合適的社區資源以獲取經濟援助及心理上的支援。不論患者患有第幾期癌症、在公營或私營機構接受治療,都可以參與此計劃。

癌症101計劃熱線電話: 立即按此打👉🏻 2733 4646

營業時間: 星期一至星期五上午九時至下午五時 (公共假期除外)

 

支持機構: (排名不分先後)

         

服務條款: 任何登記成為癌症101計劃的病人均是自願向羅氏大藥廠及其附屬公司提供所有在計劃中所需的的資料(包括聯絡資料)。計劃參與者需同意羅氏大藥廠及其附屬公司: a) 就癌症 101 計劃、藥物不良事件報告進行跟進和/分享其他信息,並通過電子郵件或電話與計劃病人聯繫。 b) 保留計劃中評估報告上的資料。羅氏大藥廠將遵守相關的個人私隱法例,即包括但不限於《個人資料(私隱)條例》,第 486 章,並採取適當的預防措施來保護計劃病人的個人資料。

免責聲明: 癌症 101 計劃中所提供的資訊僅供參考,該資訊不應替代你醫生或任何其他專業醫療人員的建議。就有關治療的建議或醫療產品的資訊,請諮詢相關及合資格的專業醫療人員。本計劃所提供的任何資訊均不用於藥品營銷並不屬醫療廣告。此計劃無意不當誘導、影響或獎勵過去、現在或未來對任何羅氏產品(包括處方推薦)的處方、供應、購買、推薦或使用。本計劃中提供的所有社區資源均基於此評估表的結果以及羅氏對該組織公開資訊的了解。羅氏對這些組織提供的服務的質量和內容不承擔任何責任。

本計劃不旨在用於記錄或報告藥物不良事件資訊,如您懷疑有任何副作用,請向您的醫生或藥劑師諮詢和報告; 如您懷疑有任何與我們產品相關的副作用或問題,請將有關資訊發送到羅氏大藥廠藥物安全部門:hong_kong.drug_safety@roche.com 。羅氏有法律義務收集並向有關的政府部門報告其藥物潛在的不良事件。在這種情況下,你的個人資料將根據特定的 GVP(良好藥物警戒規範)法例以及與藥物警戒相關的隱私政策中的描述,以最謹慎的方式處理。本計劃期間收集的個人數據將僅用於本表格中同意的目的。欲了解更多羅氏隱私政策,請參閱此鏈接: https://www.roche.com.hk/zh/privacy.html

參與者需確認已完整閱讀並理解上述條款和條件。如中英文版本有差異,請以英文版本為準。

Terms of Service: Anyone who has enrolled into Cancer 101 Program has to acknowledge that he/she has voluntarily disclosed the information required to be collected during this program (which includes personal contact information) to Roche Hong Kong Limited and its affiliates. Program patient is required to consent to Roche Hong Kong Limited and its affiliates: a) to contact he/she via email/ phone call for the purposes of this Cancer 101 program, pharmacovigilance report follow up and/or to share information and updates. b) retaining the information written on the Needs Assessment. Program patient has to acknowledge that Roche will comply with relevant privacy legislation i.e. including but not limited to the Personal Data (Privacy) Ordinance, Cap 486. and take appropriate precautions to protect my personal information.

Disclaimers: The information provided during the Cancer 101 Program serves as reference only. It should not be treated as a substitute for the medical advice of your own doctor or any other Healthcare Professionals. Please consult the relevant qualified Healthcare Professional in relation to your medical condition, for therapeutic advice or for medical product information. No information provided is for medicine marketing and constitutes a medical advertisement. This program has no intention of inappropriately induce, influence or reward the past, present or future prescribing, supply, purchasing, recommending or use of any Roche product (including formulary recommendations). All community resources supplied in this program are based on the responses of this assessment form and what is publicly available to the best knowledge of Roche. Roche bears no liability for the quality and content of services provided by these organisations.

This program is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, please contact our local pharmacovigilance unit through emailing  hong_kong.drug_safety@roche.com. Roche has the legal obligation to collect and report potential adverse events brought to its attention to Health Authorities. In such cases, your data will be processed with greatest care and diligence in accordance with specific GVP (Good pharmacovigilance practices) legislation and as described in the Privacy Policy related to pharmacovigilance. The personal data collected during this program will be used solely for the purpose as consented in this form. To learn more about Roche privacy policy, please see this link:  https://www.roche.com.hk/en/privacy.html

Anyone who are intended to enroll into Cancer 101 Program has to confirm that he/she has  read and understood the above provisions and conditions in their entirety. Should there be discrepancies between English and Chinese versions, please refer to the English version.

M-HK-00000740 valid until 07/04/2024 or until change is required in accordance with the regulator requirements, whichever comes first.